<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Clin Epigenetics</journal-id>
<journal-id journal-id-type="iso-abbrev">Clin Epigenetics</journal-id>
<journal-title-group>
<journal-title>Clinical Epigenetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1868-7075</issn>
<issn pub-type="epub">1868-7083</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30021660</article-id>
<article-id pub-id-type="pmc">6052548</article-id>
<article-id pub-id-type="publisher-id">530</article-id>
<article-id pub-id-type="doi">10.1186/s13148-018-0530-z</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Short Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genome-wide methylomic analysis in individuals with <italic>HNF1B</italic> intragenic mutation and 17q12 microdeletion</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3090-3492</contrib-id>
<name>
<surname>Clissold</surname>
<given-names>Rhian L.</given-names>
</name>
<address>
<email>rhian.clissold@nhs.net</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ashfield</surname>
<given-names>Beth</given-names>
</name>
<address>
<email>beth@themadhouse.info</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Burrage</surname>
<given-names>Joe</given-names>
</name>
<address>
<email>J.Burrage@exeter.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hannon</surname>
<given-names>Eilis</given-names>
</name>
<address>
<email>E.J.Hannon@exeter.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bingham</surname>
<given-names>Coralie</given-names>
</name>
<address>
<email>C.Bingham@exeter.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mill</surname>
<given-names>Jonathan</given-names>
</name>
<address>
<email>J.Mill@exeter.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hattersley</surname>
<given-names>Andrew</given-names>
</name>
<address>
<email>A.T.Hattersley@exeter.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Dempster</surname>
<given-names>Emma L.</given-names>
</name>
<address>
<email>E.L.Dempster@exeter.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8024</institution-id><institution-id institution-id-type="GRID">grid.8391.3</institution-id><institution>University of Exeter Medical School, </institution><institution>University of Exeter, </institution></institution-wrap>Exeter, UK </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0495 6261</institution-id><institution-id institution-id-type="GRID">grid.419309.6</institution-id><institution>Exeter Kidney Unit, </institution><institution>Royal Devon and Exeter NHS Foundation Trust, </institution></institution-wrap>Exeter, UK </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>18</day>
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>18</day>
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>10</volume>
<elocation-id>97</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>7</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Heterozygous mutation of the transcription factor <italic>HNF1B</italic> is the most common cause of monogenetic developmental renal disease. Disease-associated mutations fall into two categories: <italic>HNF1B</italic> intragenic mutations and a 1.3 Mb deletion at chromosome 17q12. An increase in neurodevelopmental disorders has been observed in individuals harbouring the 17q12 deletion but not in patients with <italic>HNF1B</italic> coding mutations.</p>
<p id="Par2">Previous investigations have concentrated on identifying a genetic cause for the increase in behavioural problems seen in 17q12 deletion carriers. We have taken the alternative approach of investigating the DNA methylation profile of these two <italic>HNF1B</italic> genotype groups along with controls matched for age, gender and diabetes status using the Illumina 450K DNA methylation array (total sample <italic>n</italic> = 60).</p>
<p id="Par3">We identified a number of differentially methylated probes (DMPs) that were associated with HNF1B-associated disease and passed our stringent experiment-wide significance threshold. These associations were largely driven by the deletion patients and the majority of the significant probes mapped to the 17q12 deletion locus. The observed changes in DNA methylation at this locus were not randomly dispersed and occurred in clusters, suggesting a regulatory mechanism reacting to haploinsufficiency across the entire deleted region.</p>
<p id="Par4">Along with these deletion-specific changes in DNA methylation, we also identified a shared DNA methylation signature in both mutation and deletion patient groups indicating that haploinsufficiency of <italic>HNF1B</italic> impacts on the methylome of a number of genes, giving further insight to the role of HNF1B.</p>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1186/s13148-018-0530-z) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Epigenetics</kwd>
<kwd>DNA methylation</kwd>
<kwd>HNF1B</kwd>
<kwd>CNV</kwd>
<kwd>17q12 deletion</kwd>
<kwd>Renal disease</kwd>
<kwd>Autism</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id>
<institution>Medical Research Council</institution>
</institution-wrap>
</funding-source>
<award-id>MR/J011630/1</award-id>
<principal-award-recipient>
<name>
<surname>Clissold</surname>
<given-names>Rhian L.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000272</institution-id>
<institution>National Institute for Health Research</institution>
</institution-wrap>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id>
<institution>Wellcome Trust</institution>
</institution-wrap>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000691</institution-id>
<institution>Academy of Medical Sciences</institution>
</institution-wrap>
</funding-source>
<award-id>Springboard</award-id>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p id="Par11">The most common monogenic cause of developmental kidney disease is heterozygous mutation of the hepatocyte nuclear factor 1β (<italic>HNF1B</italic>) gene, located at chromosome 17q12 [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR3">3</xref>]. This gene encodes a transcription factor with important roles in the development of the kidney, pancreas, genital tract and liver [<xref ref-type="bibr" rid="CR4">4</xref>]. Renal cysts are the most frequently observed clinical feature in HNF1B-associated renal disease, although the phenotype is very variable despite the single genetic aetiology [<xref ref-type="bibr" rid="CR5">5</xref>]. Abnormalities are often detected on prenatal ultrasonography, where bilateral hyperechogenic kidneys with normal or slightly increased size are commonly found [<xref ref-type="bibr" rid="CR6">6</xref>]. The prevalence of HNF1B-associated renal disease depends on which study cohort is selected; the detection rate ranges from 5% in children ≤ 16 years with renal aplasia/hypoplasia and chronic kidney disease to 31% in children with renal cysts, hyperechogenicity, hypoplasia or a single kidney [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR7">7</xref>].</p>
<p id="Par12">Extra-renal phenotypes are also common and include early-onset diabetes mellitus, pancreatic hypoplasia, genital tract malformations and abnormal liver function tests [<xref ref-type="bibr" rid="CR8">8</xref>–<xref ref-type="bibr" rid="CR13">13</xref>]. The mean age at diagnosis of diabetes is 24 years but can vary from the neonatal period to late middle age [<xref ref-type="bibr" rid="CR14">14</xref>]. The pathophysiology reflects a combination of β cell dysfunction and insulin resistance; dysfunction of β cells results in reduced insulin secretion and is likely to be a consequence of pancreatic hypoplasia [<xref ref-type="bibr" rid="CR10">10</xref>]. Most patients require treatment with insulin [<xref ref-type="bibr" rid="CR14">14</xref>].</p>
<p id="Par13">Heterozygous mutations in <italic>HNF1B</italic> generally occur in two forms; approximately 50% of patients are affected by an intragenic mutation (base substitution or small insertion/deletion within the <italic>HNF1B</italic> gene) with the other common mutation being a ~ 1.3 Mb deletion at chromosome 17q12, which encompasses the entire <italic>HNF1B</italic> gene [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. This region of chromosome 17 is susceptible to genomic rearrangement, which is mediated by non-allelic homologous recombination between flanking segmental duplications [<xref ref-type="bibr" rid="CR17">17</xref>]. Interestingly, the recurrent 17q12 deletion has also been associated with neurodevelopmental disorders, such as autism spectrum disorder and attention-deficit hyperactivity disorder [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. The 1.3 Mb deleted region contains 14 genes in addition to <italic>HNF1B</italic>, and it is not currently clear what genetic mechanism gives rise to this neurodevelopmental comorbidity. Until recently, there was no evidence to suggest a genotype-phenotype correlation for any of the other clinical features seen in HNF1B-associated disease; this is consistent with haploinsufficiency as the underlying disease mechanism [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. However, recent work by Dubois-Laforgue and colleagues has shown renal function may be worse in patients with an <italic>HNF1B</italic> intragenic mutation than in those with a deletion [<xref ref-type="bibr" rid="CR20">20</xref>].</p>
<p id="Par14">Expression of the phenotype can vary significantly between families carrying the same <italic>HNF1B</italic> mutation and even between affected members of the same family, which suggests that additional genetic and/or environmental modifiers might influence the <italic>HNF1B</italic> phenotype. Most efforts to understand this phenotypic variation have concentrated on studying changes in the DNA sequence. To date, epigenetic mechanisms which act to developmentally regulate gene expression via modifications to DNA, histone proteins and chromatin have not been explored. DNA methylation is the most well characterised and stable epigenetic modification, influencing gene expression via the disruption of transcription factor binding and the attraction of methyl-binding proteins that initiate chromatin compaction and gene silencing. DNA methylation can be directly affected by DNA sequence variation—including large structural variants—both locally (<italic>in cis</italic>) and at more distal locations in the genome (<italic>in trans</italic>) [<xref ref-type="bibr" rid="CR21">21</xref>–<xref ref-type="bibr" rid="CR24">24</xref>]. In this study, we set out to characterise the epigenetic signature of HNF1B-associated disease and to determine if the signature differs depending on mutation classification: we profiled genome-wide patterns of DNA methylation in 20 individuals with an <italic>HNF1B</italic> intragenic mutation (HNF1Bmtn), 20 individuals with a 17q12 deletion encompassing <italic>HNF1B</italic> (17q12del) and 20 controls (ctrl) matched for age, gender and diabetes status.</p>
</sec>
<sec id="Sec2">
<title>Methods</title>
<sec id="Sec3">
<title>Sample description</title>
<p id="Par15">DNA was isolated from whole blood collected from unrelated individuals with HNF1B-associated disease who had been referred for genetic testing to Exeter Molecular Genetics Laboratory from 1998 to 2012; the criterion for initial referral was suspicion of HNF1B-associated disease by the referring clinician. DNA was isolated using standard phenol:chloroform methods and checked for quality and purity. Informed consent was obtained to perform <italic>HNF1B</italic> genetic testing as part of their clinical care, and the study was conducted in agreement with the Declaration of Helsinki Principles. Mutation screening was performed by sequencing of coding exons and exon-intron boundaries together with gene dosage assessment by multiplex ligation-dependent probe amplification (MLPA) as previously described [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Control DNA was collected from two sources: (i) for individuals without diabetes mellitus, controls were individuals referred to Exeter Molecular Genetics Laboratory as above but with no <italic>HNF1B</italic> gene mutation or deletion detected on genetic testing; (ii) for individuals with diabetes mellitus, controls were individuals from the UNITED (Using pharmacogeNetics to Improve Treatment in Early-onset Diabetes) study with presumed type 1 diabetes mellitus based on a urine C-peptide/creatinine ratio ≥ 0.2 nmol/mmol with positive islet autoantibodies [<xref ref-type="bibr" rid="CR26">26</xref>]. All individuals had a serum creatinine level &lt; 250 μmol/L and were matched for age, sex and presence of diabetes (Table <xref ref-type="table" rid="Tab1">1</xref>). All samples included in the study were unrelated. Two patients in the 17q12 deletion group had known neurodevelopmental disease (a 10-year-old female with developmental delay and a 31-year-old male with Asperger’s syndrome).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Sample demographic table</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th><italic>HNF1B</italic> intragenic mutation<break></break>(<italic>n</italic> = 21)</th><th>17q12 deletion<break></break>(<italic>n</italic> = 21)</th><th>Control*<break></break>(<italic>n</italic> = 21)</th></tr></thead><tbody><tr><td>Median age, years (interquartile range)</td><td>10 (2–28)</td><td>9 (2–31)</td><td>9 (2–29)</td></tr><tr><td>Sex, <italic>n</italic> (%)</td><td>Male 8 (38)</td><td>Male 8 (38)</td><td>Male 8 (38)</td></tr><tr><td>Diabetes, <italic>n</italic> (%)</td><td>9 (43)</td><td>9 (43)</td><td>9 (43)</td></tr><tr><td colspan="4">Renal abnormality, <italic>n</italic> (%)</td></tr><tr><td> -Renal cysts/cystic dysplasia</td><td>12 (57)</td><td>12 (57)</td><td>8 (38)</td></tr><tr><td> -Renal hyperechogenicity</td><td>2 (10)</td><td>1 (5)</td><td>2 (10)</td></tr><tr><td> -Single kidney</td><td>1 (5)</td><td>1 (5)</td><td>1 (5)</td></tr><tr><td> -Multicystic and dysplastic kidney</td><td>2 (10)</td><td>2 (10)</td><td>1 (5)</td></tr><tr><td> -Obstruction</td><td>–</td><td>2 (10)</td><td>–</td></tr></tbody></table><table-wrap-foot><p>The samples were matched for age, sex and diabetes status; all individuals had a serum creatinine level &lt; 250 μmol/L</p><p>*For individuals without diabetes mellitus, controls were individuals with no <italic>HNF1B</italic> gene mutation or deletion detected on genetic testing; for individuals with diabetes mellitus, controls were individuals from the UNITED (Using pharmacogeNetics to Improve Treatment in Early-onset Diabetes) study with presumed type 1 diabetes</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec4">
<title>Methylomic profiling</title>
<p id="Par16">Blood-derived DNA was profiled using the HumanMethylation450 BeadChip (Illumina, San Diego, CA, USA) and scanned on an Illumina HiScan System (Illumina, San Diego, CA, USA). Illumina Genome Studio software was used to extract the raw signal intensities of each probe (without background correction or normalisation). Signal intensities for each probe were imported into R [<xref ref-type="bibr" rid="CR27">27</xref>] using the <italic>methylumi</italic> and <italic>minfi</italic> packages [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Multidimensional scaling plots of sex chromosome probes were used to check that the predicted sex corresponded with the reported sex for each individual. The 65 SNP probes, cross-hybridising probes [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>] and probes containing a SNP 10 bp from the extension position (MAF &gt; 0.05) were excluded from analysis [<xref ref-type="bibr" rid="CR30">30</xref>]. The ‘pfilter’ function of the <italic>wateRmelon</italic> package [<xref ref-type="bibr" rid="CR32">32</xref>] was used to filter data by beadcount and detection <italic>P</italic> value. Samples with &gt; 1% probes with a detection <italic>P</italic>value &gt; 0.01 were removed, along with probes with a detection <italic>P</italic> value &gt; 0.05 in at least 1% of samples and/or a beadcount &lt; 3 in 5% of samples were also removed. The ‘dasen’ function in <italic>wateRmelon</italic> was used to normalise the data as previously described [<xref ref-type="bibr" rid="CR32">32</xref>]. The number of samples that passed quality control was 60 (<italic>HNF1B</italic> intragenic mutation (<italic>n</italic> = 20), 17q12 deletion (<italic>n</italic> = 20) and control (<italic>n</italic> = 20) and a total of 388,295 CpG sites were included in the final dataset.</p>
</sec>
<sec id="Sec5">
<title>Bisulfite pyrosequencing</title>
<p id="Par17">A selected region was chosen to verify the array findings using the complementary technology of bisulfite pyrosequencing using the Qiagen Q24 Pyrosequencer (Qiagen, Hilden, Germany) (see [<xref ref-type="bibr" rid="CR33">33</xref>]). Primers, probes and the PCR conditions for the selected region can be found in Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1; the sequencing reaction was performed using the manufacturer’s protocol.</p>
</sec>
<sec id="Sec6">
<title>Statistical analysis</title>
<sec id="Sec7">
<title>Differentially methylated position (DMP)</title>
<p id="Par18">The one-way analysis of variance (ANOVA) test was used to test for differentially methylated sites associated with one of the three groups: <italic>HNF1B</italic> intragenic mutation (<italic>n</italic> = 20), 17q12 deletion (<italic>n</italic> = 20) or control (<italic>n</italic> = 20). DNA methylation values for each probe were regressed against <italic>HNF1B</italic> status with covariates for age, gender, diabetes status and cellular composition. As cell count data were not available for these DNA samples these were estimated from the DNA methylation data using both the Epigenetic Clock software [<xref ref-type="bibr" rid="CR34">34</xref>] and the Houseman algorithm [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. To determine which group was driving the association behind the significant ANOVA results, the <italic>T</italic> statistics for controls versus each of the two <italic>HNF1B</italic> distinct genetic groups were extracted from the regression model. The presence of the 17q12 deletion was confirmed by analysing the DNA methylation raw data using the function ‘champ.CNA’ from the package ChAMP [<xref ref-type="bibr" rid="CR37">37</xref>].</p>
</sec>
<sec id="Sec8">
<title>Differentially methylated regions (DMRs)</title>
<p id="Par19">The <italic>P</italic> values for the comparisons between the control group and <italic>HNF1B</italic> genotype status from the regression analysis were converted into BED files and run through the <italic>comb-p</italic> [<xref ref-type="bibr" rid="CR38">38</xref>] pipeline with a seed of (5 × 10<sup>−4</sup>) and distance parameter set to 500 bp. Briefly, <italic>comb-p</italic> generates DMRs by (1) calculating the auto-correlation between probes to adjust the input DMP <italic>P</italic> values using the Stouffer-Liptak-Kechris correction, (2) running a peak finding algorithm over these adjusted <italic>P</italic> values to identify enriched regions around a seed signal, 3) calculating region <italic>P</italic> value using the Stouffer-Liptak correction and (4) correcting for multiple testing with the one-step Šidák correction. Significant regions were identified as those with at least two probes and corrected <italic>P</italic> value &lt; 0.05.</p>
</sec>
</sec>
</sec>
<sec id="Sec9">
<title>Results</title>
<p id="Par20">All samples characterised as 17q12 deletion carriers were confirmed by the CNV calling function in CHAMP which uses the intensity data from the DNA methylation array (see Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Figure S1). The probe-wise ANOVA analysis on the three groups <italic>(HNF1B</italic> intragenic mutation, 17q12 deletion and control) identified 21 differentially methylated positions (DMPs) (see Table <xref ref-type="table" rid="Tab2">2</xref>) that passed our experiment-wide significance threshold (<italic>P</italic> &lt; 1 × 10<sup>−7</sup>), representing a 5% family-wise error-rate estimated from 5000 permutations (see [<xref ref-type="bibr" rid="CR39">39</xref>]), with 94 additional DMPs reaching a more relaxed ‘discovery’ threshold of <italic>P</italic> &lt; 5 × 10<sup>−5</sup> (Additional file <xref ref-type="media" rid="MOESM3">3</xref>: Table S2). To determine which group was driving this association, we extracted the <italic>P</italic> values for the <italic>T</italic> statistics from the model <italic>HNF1B</italic> intragenic mutation vs control and 17q12 deletion vs control; these results clearly show that the 17q12 deletion group is driving most of the associations seen in the ANOVA (see Table <xref ref-type="table" rid="Tab2">2</xref>). All of the significant DMPs (<italic>P</italic> &lt; 1 × 10<sup>−7</sup>) are located in the 17q12 deletion region (see Figs. <xref ref-type="fig" rid="Fig1">1</xref> and <xref ref-type="fig" rid="Fig2">2</xref>) suggesting that the deletion is exerting effects in cis. While this region appears to be driving the main associations observed, probes situated outside the deletion region, which are associated with both <italic>HNF1B</italic> genotype groups, are strongly correlated (<italic>r</italic> = 0.63, <italic>P</italic> = 2.626E−07); see Fig. <xref ref-type="fig" rid="Fig3">3</xref> and Additional file <xref ref-type="media" rid="MOESM4">4</xref>: Table S3 for a list of probes that are significantly differently methylated in both <italic>HNF1B</italic> genotype groups compared to controls.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Top results from the probe-wise ANOVA analysis. The T statistic results from the regression analysis indicate that the association is mainly driven by the 17q12 deletion patients. DMP results are annotated with their genomic location and gene annotation taken from the annotation files provided by Illumina. (*The coefficient value is equivalent to the magnitude of change in DNA methylation beta value and the direction of effect is in comparison to the control group)</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Illumina Probe ID</th><th rowspan="2"><italic>F</italic> statistic</th><th rowspan="2">ANOVA <italic>P</italic> value</th><th rowspan="2">ANOVA <italic>q</italic> values</th><th rowspan="2">CHR</th><th rowspan="2">MAPINFO (hg19)</th><th rowspan="2">Gene name</th><th colspan="3">ctrl v 17q12del</th><th colspan="3">ctrl vs HNF1B mtn</th></tr><tr><th><italic>T</italic> statistic</th><th>Coefficient*</th><th><italic>P</italic> value</th><th><italic>T</italic> statistic</th><th>Coefficient*</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td>cg06475972</td><td>47.017</td><td>4.00E-12</td><td>1.55E−06</td><td>17</td><td>34842357</td><td>ZNHIT3</td><td>9.045</td><td>0.043</td><td>5.06E−12</td><td>0.074</td><td>0.000</td><td>0.942</td></tr><tr><td>cg17953633</td><td>43.696</td><td>1.28E−11</td><td>2.49E−06</td><td>17</td><td>34957751</td><td>MRM1</td><td>8.532</td><td>0.069</td><td>2.97E−11</td><td>−0.417</td><td>− 0.003</td><td>0.678</td></tr><tr><td>cg24685795</td><td>40.277</td><td>4.52E−11</td><td>5.84E−06</td><td>17</td><td>34851276</td><td>ZNHIT3</td><td>− 8.075</td><td>− 0.107</td><td>1.47E−10</td><td>0.674</td><td>0.008</td><td>0.504</td></tr><tr><td>cg18269801</td><td>37.212</td><td>1.48E−10</td><td>1.44E−05</td><td>17</td><td>35732756</td><td>ACACA</td><td>− 8.088</td><td>− 0.061</td><td>1.40E−10</td><td>− 0.184</td><td>− 0.001</td><td>0.855</td></tr><tr><td>cg05527869</td><td>35.891</td><td>2.52E−10</td><td>1.95E−05</td><td>17</td><td>35294476</td><td>LHX1</td><td>7.988</td><td>0.025</td><td>1.99E−10</td><td>0.310</td><td>0.001</td><td>0.758</td></tr><tr><td>cg04264908</td><td>35.376</td><td>3.10E−10</td><td>2.01E−05</td><td>17</td><td>35303330</td><td></td><td>8.057</td><td>0.060</td><td>1.56E−10</td><td>0.716</td><td>0.005</td><td>0.477</td></tr><tr><td>cg22359664</td><td>32.781</td><td>9.19E−10</td><td>5.10E−05</td><td>17</td><td>35289432</td><td></td><td>7.094</td><td>0.044</td><td>4.75E−09</td><td>− 1.023</td><td>− 0.006</td><td>0.311</td></tr><tr><td>cg07037057</td><td>30.723</td><td>2.25E−09</td><td>0.000107005</td><td>17</td><td>35969138</td><td>SYNRG</td><td>7.684</td><td>0.076</td><td>5.84E−10</td><td>1.382</td><td>0.012</td><td>0.173</td></tr><tr><td>cg18103097</td><td>30.332</td><td>2.68E−09</td><td>0.000107005</td><td>17</td><td>35414317</td><td></td><td>− 7.386</td><td>− 0.071</td><td>1.68E−09</td><td>− 0.415</td><td>− 0.004</td><td>0.680</td></tr><tr><td>cg20151045</td><td>30.270</td><td>2.76E−09</td><td>0.000107005</td><td>17</td><td>35414114</td><td>AATF</td><td>− 7.242</td><td>− 0.051</td><td>2.80E−09</td><td>− 0.018</td><td>0.000</td><td>0.986</td></tr><tr><td>cg20951949</td><td>29.512</td><td>3.88E−09</td><td>0.000136867</td><td>17</td><td>34898162</td><td></td><td>− 7.047</td><td>− 0.078</td><td>5.60E−09</td><td>0.254</td><td>0.003</td><td>0.801</td></tr><tr><td>ch.17.958355F</td><td>28.600</td><td>5.89E−09</td><td>0.000190431</td><td>17</td><td>35991457</td><td>DDX52</td><td>7.365</td><td>0.055</td><td>1.81E−09</td><td>1.110</td><td>0.008</td><td>0.273</td></tr><tr><td>cg19678067</td><td>27.750</td><td>8.74E−09</td><td>0.00026103</td><td>17</td><td>34901173</td><td>GGNBP2</td><td>6.725</td><td>0.033</td><td>1.77E−08</td><td>− 0.509</td><td>− 0.002</td><td>0.613</td></tr><tr><td>cg06655187</td><td>27.194</td><td>1.14E−08</td><td>0.000315011</td><td>17</td><td>34842929</td><td>ZNHIT3</td><td>7.335</td><td>0.018</td><td>2.01E−09</td><td>1.984</td><td>0.004</td><td>0.053</td></tr><tr><td>cg03146993</td><td>26.915</td><td>1.30E−08</td><td>0.000335768</td><td>17</td><td>35297146</td><td>LHX1</td><td>6.987</td><td>0.041</td><td>6.95E−09</td><td>0.487</td><td>0.003</td><td>0.628</td></tr><tr><td>cg18574725</td><td>26.761</td><td>1.40E−08</td><td>0.000338748</td><td>17</td><td>34900600</td><td>GGNBP2</td><td>6.659</td><td>0.032</td><td>2.24E−08</td><td>− 0.370</td><td>− 0.002</td><td>0.713</td></tr><tr><td>cg06397845</td><td>26.545</td><td>1.55E−08</td><td>0.000353603</td><td>17</td><td>35732737</td><td>ACACA</td><td>− 6.809</td><td>− 0.066</td><td>1.31E−08</td><td>− 0.092</td><td>− 0.001</td><td>0.927</td></tr><tr><td>cg00356511</td><td>26.177</td><td>1.85E−08</td><td>0.000398715</td><td>17</td><td>35716273</td><td>ACACA</td><td>6.279</td><td>0.024</td><td>8.68E−08</td><td>− 1.035</td><td>− 0.004</td><td>0.306</td></tr><tr><td>cg02787306</td><td>25.017</td><td>3.26E−08</td><td>0.000665877</td><td>17</td><td>34957963</td><td>MRM1</td><td>6.652</td><td>0.044</td><td>2.29E−08</td><td>0.209</td><td>0.001</td><td>0.835</td></tr><tr><td>cg27614319</td><td>24.275</td><td>4.72E−08</td><td>0.000916069</td><td>17</td><td>35079061</td><td></td><td>6.453</td><td>0.040</td><td>4.68E−08</td><td>− 0.073</td><td>0.000</td><td>0.942</td></tr><tr><td>cg04993975</td><td>24.159</td><td>5.00E−08</td><td>0.000924571</td><td>17</td><td>35294472</td><td>LHX1</td><td>6.648</td><td>0.024</td><td>2.33E−08</td><td>0.555</td><td>0.002</td><td>0.582</td></tr></tbody></table></table-wrap><fig id="Fig1"><label>Fig. 1</label><caption><p>Manhattan plots of the three analyses. <bold>a</bold>
<italic>P</italic> values from the ANOVA test on the three genotype groups (HNF1B intergenic mutation, 17q12 deletion and controls). Highlighted in green are the 450K probes that are located in the 17q12 deletion region. <bold>b</bold>
<italic>P</italic> values from the <italic>T</italic> statistic from the regression model on controls compared to the 17q12 deletion samples. <bold>c</bold>
<italic>P</italic> values from the <italic>T</italic> statistic from the regression model on controls compared to the <italic>HNF1B</italic> mutation samples. (The red line indicates experiment-wide significance threshold (<italic>P</italic> &lt; 1 × 10<sup>−7</sup>), and the blue line is a more relaxed ‘discovery’ threshold of <italic>P</italic> &lt; 5 × 10<sup>–5</sup>)</p></caption><graphic id="MO1" xlink:href="13148_2018_530_Fig1_HTML"></graphic></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>This figure illustrates the 17q12 deletion locus with the identified DMRs highlighted across the region. The regression coefficient and <italic>P</italic> values from the analysis comparing the 17q12 deletion subject with controls illustrates that both hyper and hypo DNA methylation changes are associated with the deletion</p></caption><graphic id="MO2" xlink:href="13148_2018_530_Fig2_HTML"></graphic></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>This scatterplot demonstrates the concordance in effect size between the two <italic>HNF1B</italic> genetic groups compared to controls when probes in the 17q12 deletion region (coloured green) are discounted</p></caption><graphic id="MO3" xlink:href="13148_2018_530_Fig3_HTML"></graphic></fig></p>
<p id="Par21">DMR analysis comparing controls with the 17q12 deletion group identified a number of regions that were significant after correction for multiple comparisons using the comb-p program (Table <xref ref-type="table" rid="Tab3">3</xref>). The majority of the DMRs identified were located in the 17q12 deletion region (Fig. <xref ref-type="fig" rid="Fig2">2</xref>). However, there were a few regions outside the deletion region that exhibited significant differential methylation; of interest were changes in the gene <italic>SLC1A3</italic> (<italic>corrected P =</italic> 4.71E−07, mean DNA methylation beta value Δ − 0.06), which has previously been implicated in Autism [<xref ref-type="bibr" rid="CR40">40</xref>]. The DMR located in intron 3 of this gene was selected for verification with pyrosequencing. The assay designed only covered two of the three original probes comprising the DMR but did include an additional five CpG sites that were not present on the 450K array. The pyrosequencing data was converted into beta values (by dividing the pyrosequencing % values by 100) and regressed against <italic>HNF1B</italic> status with covariates for age, diabetes status, gender and cell composition as in the initial analysis. The five additional sites assayed by the pyrosequencer all showed significant hypomethylation (<italic>P</italic> &lt; 0.01) in the 17q12 deletion patients compared to the controls (see Fig. <xref ref-type="fig" rid="Fig4">4</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Differential methylation regional (DMR) analysis on the two HNF1B deficient groups of patients compared to the controls (highlighted in blue is the DMR residing in the gene <italic>SLC1A3</italic> which was validated using pyrosequencing)</p></caption><graphic id="MO4" xlink:href="13148_2018_530_Tab3_HTML"></graphic></table-wrap><fig id="Fig4"><label>Fig. 4</label><caption><p>This figure shows the validation of the DMR located in the gene <italic>SLC1A3</italic> with bisulfite pyrosequencing. All CpGs assayed, including those not present on the 450K array, show significant hypomethylation in subjects harbouring a 17q12 deletion</p></caption><graphic id="MO5" xlink:href="13148_2018_530_Fig4_HTML"></graphic></fig></p>
<p id="Par22">In contrast, only one significant DMR was located in the analysis comparing controls with the <italic>HNF1B</italic> mutation group (see Table <xref ref-type="table" rid="Tab3">3</xref>).</p>
</sec>
<sec id="Sec10">
<title>Discussion</title>
<p id="Par23">In this study, we have assessed genome-wide patterns of DNA methylation in DNA derived from the blood of individuals with HNF1B-associated disease along with matched healthy controls. The aim of this experiment was to determine if there was an epigenetic signature that can distinguish <italic>HNF1B</italic> intragenic mutation patients from those with a 17q12 deletion. While both genotype groups result in developmental kidney disease only individuals with the 17q12 deletion appear to have a greater risk of developing neuropsychiatric symptoms, suggesting the contribution of other genes or regulatory mechanisms are at play.</p>
<p id="Par24">We first examined site-specific genome-wide patterns of DNA methylation in the three groups studied (<italic>HNF1B</italic> mutations, 17q12 deletion and controls) and found striking changes in DNA methylation of the 17q12 deletion region. The 21 DMPs that reached our experimental-wide significance threshold all mapped to the 17q12 deletion region. While we do see a drop in signal intensity in this region in the deletion samples, it is consistent across the methylated and unmethylated channels so will not influence the calculated beta values. Interestingly, the direction of effect is not consistent, with probes exhibiting both gains and losses of DNA methylation suggesting the observed changes are not a technical artefact on the array resulting from the haploinsufficiency of the region. Comparing the two <italic>HNF1B</italic> genotype groups with controls separately confirmed that the association located to the 1.3 Mb deletion at chromosome 17q12 was driven by the 17q12 deletion samples.</p>
<p id="Par25">Given that DNA methylation at adjacent probes is often correlated, we employed regional-based analysis and identified 20 DMRs in the 17q12 deletion samples, 13 of which were located in the 1.3 Mb deletion region. The most significant DMR mapped upstream of the gene <italic>LHX1 (</italic>corrected <italic>P =</italic> 3.37E−18, mean DNA methylation beta Δ + 0.02) (see Additional file <xref ref-type="media" rid="MOESM5">5</xref>: Figure S2), which is known to play a role in brain development and function [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>] as well as being directly regulated by <italic>HNF1B</italic> during kidney development [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>].</p>
<p id="Par26">These observations suggest a possible compensatory mechanism mediated by DNA methylation reacting to haploinsufficiency in the vicinity of the deletion. The enrichment of DMRs in this region indicates that this phenomenon is not entirely random and highlights a number of loci in the region that may have regulatory importance. Recently, DNA methylation has been found to have a major role in “fine-tuning” the expression of genes located in CNVs found in various different cancers [<xref ref-type="bibr" rid="CR45">45</xref>].</p>
<p id="Par27">While there is a substantial enrichment of DMRs in the deletion region a number of DMRs were identified elsewhere in the genome, one of which was located in the gene <italic>SLC1A3</italic> on chromosome 5. Genetic variations in this gene have been linked to autism and expression changes in this gene have been identified in schizophrenia patients; both these disorders have been associated with the 17q12 deletion [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. Further work is needed to identify whether alterations in the DNA methylation profile in this gene affect gene function.</p>
<p id="Par28">So far, we have concentrated on the differences in the DNA methylation signature in the 17q12 deletion subjects which are not shared by the <italic>HNF1B</italic> mutation subjects. However, these two groups have similar phenotypes and this was reflected in the DNA methylation profile of the two groups once the probes located in the 17q12 region are removed, indicating that there is a shared network of genes that are dysregulated due to the haploinsufficency of <italic>HNF1B</italic> (see Fig. <xref ref-type="fig" rid="Fig3">3</xref> and Additional file <xref ref-type="media" rid="MOESM4">4</xref>: Table S3). The majority of these shared probes are significantly hypomethylated in both patient groups compared to controls and include cg01445838 (17q12del vs control <italic>P</italic> = 5.38E−05, coefficient = − 0.064, HNF1B mutation vs control <italic>P</italic> = 0.000213, coefficient = − 0.052), which is located in the maternally imprinted gene <italic>PLAGL1</italic>. This gene is known to be involved in fetal growth and is necessary for normal pancreatic islet development [<xref ref-type="bibr" rid="CR47">47</xref>]. Furthermore, loss of DNA methylation at this locus results in transient neonatal diabetes mellitus which is postulated to be caused by an increase in expression of PLAGL1 [<xref ref-type="bibr" rid="CR48">48</xref>].</p>
<p id="Par29">The main limitation of this study is that it uses blood-derived DNA and not disease-relevant tissue and/or cells (e.g. the kidney or the brain). However, genetic-mediated changes in DNA methylation (methylation QTLS) have been found to be considerably stable across different tissues and cell types [<xref ref-type="bibr" rid="CR39">39</xref>] suggesting that we may be able to extrapolate these findings to other more relevant tissues.</p>
<p id="Par30">Clinical details were taken from information available at the time of referral for genetic testing; there may be patient factors present, including medication history, which we have been unable to control for and may have influenced our results. Further, we also do not have detailed psychiatric data available for the samples included in this study so we cannot make any assumptions regarding the DNA methylation status of the 17q12 deletion and the increased prevalence of psychiatric symptoms. Many of the individuals were too young to be assessed for schooling difficulties and the features of neurodevelopmental disease often do not become apparent until children are older.</p>
</sec>
<sec id="Sec11">
<title>Conclusion</title>
<p id="Par31">We have identified significant DNA methylation alterations in individuals with a 17q12 heterozygous deletion, which localise to a 1.3 Mb deletion region. The observed changes in DNA methylation at this locus are not randomly dispersed and occur in clusters suggesting a regulatory mechanism reacting to haploinsufficiency across the deleted region. Along with these deletion-specific changes in DNA methylation, we also identified a common DNA methylation signature in both genotype groups, indicating that haploinsufficiency of <italic>HNF1B</italic> impacts on the methylome of a number of genes. Further work should investigate the role of these genes in the manifestation of the various phenotypes associated with deficiency of HNF1B and investigate gene expression changes associated with DNA methylation status across the deletion region in disease relevant tissues. Also the increased prevalence of psychiatric symptoms in patients with the 17q12 deletion should be considered and whether alterations in DNA methylation in this region differ depending on psychiatric diagnosis.</p>
<p id="Par32">Due to the rare nature of HNF1B mutations/deletions, validation of these findings in an independent population was not possible in this study but further work should investigate DNA methylation changes <italic>in cis</italic> of other more common disease associated copy number variations.</p>
<p id="Par33">To conclude, we have identified several genes that are differentially methylated in HNF1B-associated disease, some of which are specific to 17q12 deletion subjects. Further, this study is, as far as we are aware, the first to document organised changes in DNA methylation across a large deletion region suggestive of a compensational role of this epigenetic modification.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Additional files</title>
<sec id="Sec12">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13148_2018_530_MOESM1_ESM.xlsx"><label>Additional file 1:</label><caption><p><bold>Table S1.</bold> SLC1A3 bisulfite pyrosequencing assay conditions. (XLSX 11 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="13148_2018_530_MOESM2_ESM.pdf"><label>Additional file 2:</label><caption><p><bold>Figure S1.</bold> This figure illustrates the extent of the 17q12 deletion in each patient as estimated by the CNV calling algorithm within the CHAMP package. (PDF 15 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="13148_2018_530_MOESM3_ESM.xlsx"><label>Additional file 3:</label><caption><p><bold>Table S2.</bold> All anlaysed probes from the ANOVA test with a <italic>p</italic>-value &lt;0.01. (XLSX 688 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="13148_2018_530_MOESM4_ESM.xlsx"><label>Additional file 4:</label><caption><p><bold>Table S3.</bold> Probes that are significantly differentaly methylated in both of the separate group analyses (note that all probes are in the same direction in both analyses). (XLSX 19 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="13148_2018_530_MOESM5_ESM.pdf"><label>Additional file 5:</label><caption><p><bold>Figure S2.</bold> This Figure shows four significant differentially methylated regions (DMRs) identified between controls and 17q12 deletion carriers. A) <italic>SYNRG</italic> (corrected <italic>P</italic> = 1.32E-17), B) <italic>AATF</italic> (corrected <italic>P</italic> = 1.64E-11). C) <italic>LHX1</italic> (corrected <italic>P =</italic> 3.37E-18), D) <italic>SMIM24</italic> (corrected <italic>P =</italic> 1.01E-07). (PDF 223 kb)</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>ANOVA</term>
<def>
<p id="Par5">Analysis of variance</p>
</def>
</def-item>
<def-item>
<term>CNV</term>
<def>
<p id="Par6">Copy number variant</p>
</def>
</def-item>
<def-item>
<term>DMP</term>
<def>
<p id="Par7">Differentially methylated position</p>
</def>
</def-item>
<def-item>
<term>DMR</term>
<def>
<p id="Par8">Differentially methylated region</p>
</def>
</def-item>
<def-item>
<term>HNF1B</term>
<def>
<p id="Par9">Hepatocyte nuclear factor 1β</p>
</def>
</def-item>
<def-item>
<term>SNP</term>
<def>
<p id="Par10">Single nucleotide polymorphism</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Electronic supplementary material</bold>
</p>
<p>The online version of this article (10.1186/s13148-018-0530-z) contains supplementary material, which is available to authorized users.</p>
</fn>
</fn-group>
<ack>
<sec id="FPar1">
<title>Funding</title>
<p id="Par34">RC is supported by a Medical Research Council Clinical Training Fellowship (grant reference number MR/J011630/1). AH is a core member of the NIHR Exeter Clinical Research Facility and a National Institute for Health Research Senior Investigator; he is also supported by a Wellcome Trust Senior Investigator award. ED is a recipient of an Academy of Medical Sciences Springboard Award.</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p id="Par35">The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>AH, JM, ED and RC conceived the idea for the study. ED and RC collected and analysed the data. BA performed the pyrosequencing. All co-authors contributed to discussions regarding the results. ED and RC wrote the manuscript; all authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar3">
<title>Ethics approval and consent to participate</title>
<p id="Par36">Use of the Health Research Authority decision tool confirmed that approval by an NHS Research Ethics Committee was not required. Informed consent was obtained from individuals to perform <italic>HNF1B</italic> genetic testing as part of clinical care, and the study was conducted in agreement with the Declaration of Helsinki Principles.</p>
</sec>
<sec id="FPar4">
<title>Consent for publication</title>
<p id="Par37">Not applicable.</p>
</sec>
<sec id="FPar5">
<title>Competing interests</title>
<p id="Par38">The authors declare that they have no competing interests.</p>
</sec>
<sec id="FPar6">
<title>Publisher’s Note</title>
<p id="Par39">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weber</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Moriniere</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Knuppel</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Charbit</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dusek</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ghiggeri</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Jankauskiene</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mir</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Montini</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Peco-Antic</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence of mutations in renal developmental genes in children with renal hypodysplasia: results of the ESCAPE study</article-title>
<source/>J Am Soc Nephrol
          <year>2006</year>
<volume>17</volume>
<fpage>2864</fpage>
<lpage>2870</lpage>
<pub-id pub-id-type="doi">10.1681/ASN.2006030277</pub-id>
<pub-id pub-id-type="pmid">16971658</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sanna-Cherchi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Warady</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Furth</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Kaskel</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Gharavi</surname>
<given-names>AG</given-names>
</name>
</person-group>
<article-title>HNF1B and PAX2 mutations are a common cause of renal hypodysplasia in the CKiD cohort</article-title>
<source/>Pediatr Nephrol
          <year>2011</year>
<volume>26</volume>
<fpage>897</fpage>
<lpage>903</lpage>
<pub-id pub-id-type="doi">10.1007/s00467-011-1826-9</pub-id>
<pub-id pub-id-type="pmid">21380624</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madariaga</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Moriniere</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Jeanpierre</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bouvier</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Loget</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Martinovic</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dechelotte</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Leporrier</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Thauvin-Robinet</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>UB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Severe prenatal renal anomalies associated with mutations in HNF1B or PAX2 genes</article-title>
<source/>Clin J Am Soc Nephrol
          <year>2013</year>
<volume>8</volume>
<fpage>1179</fpage>
<lpage>1187</lpage>
<pub-id pub-id-type="doi">10.2215/CJN.10221012</pub-id>
<pub-id pub-id-type="pmid">23539225</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coffinier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Barra</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Babinet</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yaniv</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Expression of the vHNF1/HNF1beta homeoprotein gene during mouse organogenesis</article-title>
<source/>Mech Dev
          <year>1999</year>
<volume>89</volume>
<fpage>211</fpage>
<lpage>213</lpage>
<pub-id pub-id-type="doi">10.1016/S0925-4773(99)00221-X</pub-id>
<pub-id pub-id-type="pmid">10559500</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heidet</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Decramer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pawtowski</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Moriniere</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bandin</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Knebelmann</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lebre</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Faguer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Guigonis</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Antignac</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Salomon</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases</article-title>
<source/>Clin J Am Soc Nephrol
          <year>2010</year>
<volume>5</volume>
<fpage>1079</fpage>
<lpage>1090</lpage>
<pub-id pub-id-type="doi">10.2215/CJN.06810909</pub-id>
<pub-id pub-id-type="pmid">20378641</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Decramer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Parant</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Beaufils</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Clauin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Guillou</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kessler</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Aziza</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bandin</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Schanstra</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Bellanne-Chantelot</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys</article-title>
<source/>J Am Soc Nephrol
          <year>2007</year>
<volume>18</volume>
<fpage>923</fpage>
<lpage>933</lpage>
<pub-id pub-id-type="doi">10.1681/ASN.2006091057</pub-id>
<pub-id pub-id-type="pmid">17267738</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ulinski</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lescure</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Beaufils</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Guigonis</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Decramer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Morin</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Clauin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Deschenes</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bouissou</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bensman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bellanne-Chantelot</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Renal phenotypes related to hepatocyte nuclear factor-1beta (TCF2) mutations in a pediatric cohort</article-title>
<source/>J Am So Nephrol
          <year>2006</year>
<volume>17</volume>
<fpage>497</fpage>
<lpage>503</lpage>
<pub-id pub-id-type="doi">10.1681/ASN.2005101040</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bingham</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bulman</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Ellard</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>LI</given-names>
</name>
<name>
<surname>Lipkin</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Hoff</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Woolf</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Rizzoni</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Novelli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nicholls</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Hattersley</surname>
<given-names>AT</given-names>
</name>
</person-group>
<article-title>Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease</article-title>
<source/>Am J Hum Genet
          <year>2001</year>
<volume>68</volume>
<fpage>219</fpage>
<lpage>224</lpage>
<pub-id pub-id-type="doi">10.1086/316945</pub-id>
<pub-id pub-id-type="pmid">11085914</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bellanne-Chantelot</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chauveau</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gautier</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Dubois-Laforgue</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Clauin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Beaufils</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wilhelm</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Boitard</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Noel</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Velho</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Timsit</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations</article-title>
<source/>Ann Intern Med
          <year>2004</year>
<volume>140</volume>
<fpage>510</fpage>
<lpage>517</lpage>
<pub-id pub-id-type="doi">10.7326/0003-4819-140-7-200404060-00009</pub-id>
<pub-id pub-id-type="pmid">15068978</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haldorsen</surname>
<given-names>IS</given-names>
</name>
<name>
<surname>Vesterhus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Raeder</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Sovik</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Molven</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Njolstad</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>Lack of pancreatic body and tail in HNF1B mutation carriers</article-title>
<source/>Diabet Med
          <year>2008</year>
<volume>25</volume>
<fpage>782</fpage>
<lpage>787</lpage>
<pub-id pub-id-type="doi">10.1111/j.1464-5491.2008.02460.x</pub-id>
<pub-id pub-id-type="pmid">18644064</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwasaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ogata</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tomonaga</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Kuroki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kasahara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yano</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Iwamoto</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Liver and kidney function in Japanese patients with maturity-onset diabetes of the young</article-title>
<source/>Diabetes Care
          <year>1998</year>
<volume>21</volume>
<fpage>2144</fpage>
<lpage>2148</lpage>
<pub-id pub-id-type="doi">10.2337/diacare.21.12.2144</pub-id>
<pub-id pub-id-type="pmid">9839108</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montoli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Colussi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Massa</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Caccia</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rizzoni</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Civati</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Barbetti</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Renal cysts and diabetes syndrome linked to mutations of the hepatocyte nuclear factor-1 beta gene: description of a new family with associated liver involvement</article-title>
<source/>Am J Kidney Dis
          <year>2002</year>
<volume>40</volume>
<fpage>397</fpage>
<lpage>402</lpage>
<pub-id pub-id-type="doi">10.1053/ajkd.2002.34538</pub-id>
<pub-id pub-id-type="pmid">12148114</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lindner</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Njolstad</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Horikawa</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bostad</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>GI</given-names>
</name>
<name>
<surname>Sovik</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1beta</article-title>
<source/>Hum Mol Genet
          <year>1999</year>
<volume>8</volume>
<fpage>2001</fpage>
<lpage>2008</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/8.11.2001</pub-id>
<pub-id pub-id-type="pmid">10484768</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>YZ</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>XZ</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>XS</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>YQ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>XM</given-names>
</name>
</person-group>
<article-title>Systematic review of TCF2 anomalies in renal cysts and diabetes syndrome/maturity onset diabetes of the young type 5</article-title>
<source/>Chin Med J
          <year>2010</year>
<volume>123</volume>
<fpage>3326</fpage>
<lpage>3333</lpage>
<pub-id pub-id-type="pmid">21163139</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bellanne-Chantelot</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Clauin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chauveau</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Collin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Daumont</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Douillard</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dubois-Laforgue</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dusselier</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gautier</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Jadoul</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5</article-title>
<source/>Diabetes
          <year>2005</year>
<volume>54</volume>
<fpage>3126</fpage>
<lpage>3132</lpage>
<pub-id pub-id-type="doi">10.2337/diabetes.54.11.3126</pub-id>
<pub-id pub-id-type="pmid">16249435</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edghill</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Oram</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Owens</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Stals</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Harries</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Hattersley</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Ellard</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bingham</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Hepatocyte nuclear factor-1beta gene deletions—a common cause of renal disease</article-title>
<source/>Nephrol Dial Transplant
          <year>2008</year>
<volume>23</volume>
<fpage>627</fpage>
<lpage>635</lpage>
<pub-id pub-id-type="doi">10.1093/ndt/gfm603</pub-id>
<pub-id pub-id-type="pmid">17971380</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mefford</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Clauin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sharp</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Moller</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Ullmann</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kapur</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pinkel</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Ventura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ropers</surname>
<given-names>HH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Recurrent reciprocal genomic rearrangements of 17q12 are associated with renal disease, diabetes, and epilepsy</article-title>
<source/>Am J Hum Genet
          <year>2007</year>
<volume>81</volume>
<fpage>1057</fpage>
<lpage>1069</lpage>
<pub-id pub-id-type="doi">10.1086/522591</pub-id>
<pub-id pub-id-type="pmid">17924346</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreno-De-Luca</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mulle</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Kaminsky</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Adam</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Pakula</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Eisenhauer</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Uhas</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Weik</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia</article-title>
<source/>Am J Hum Genet
          <year>2010</year>
<volume>87</volume>
<fpage>618</fpage>
<lpage>630</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2010.10.004</pub-id>
<pub-id pub-id-type="pmid">21055719</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clissold</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Shaw-Smith</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Turnpenny</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bunce</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bockenhauer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kerecuk</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Waller</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bowman</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ford</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ellard</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Chromosome 17q12 microdeletions but not intragenic HNF1B mutations link developmental kidney disease and psychiatric disorder</article-title>
<source/>Kidney Int
          <year>2016</year>
<volume>90</volume>
<fpage>203</fpage>
<lpage>211</lpage>
<pub-id pub-id-type="doi">10.1016/j.kint.2016.03.027</pub-id>
<pub-id pub-id-type="pmid">27234567</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dubois-Laforgue</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cornu</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Saint-Martin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Coste</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bellanné-Chantelot</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Timsit</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Diabetes, Associated Clinical Spectrum, Long-term Prognosis, and Genotype/Phenotype Correlations in 201 Adult Patients With Hepatocyte Nuclear Factor 1B (HNF1B) Molecular Defects</article-title>
<source/>Diabetes Care.
          <year>2017</year>
<volume>40</volume>
<fpage>1436</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.2337/dc16-2462</pub-id>
<pub-id pub-id-type="pmid">28420700</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bell</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Pai</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Pickrell</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Gaffney</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Pique-Regi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Degner</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Gilad</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Pritchard</surname>
<given-names>JK</given-names>
</name>
</person-group>
<article-title>DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines</article-title>
<source/>Genome Biol
          <year>2011</year>
<volume>12</volume>
<fpage>R10</fpage>
<pub-id pub-id-type="doi">10.1186/gb-2011-12-1-r10</pub-id>
<pub-id pub-id-type="pmid">21251332</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gibbs</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>van der Brug</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Hernandez</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Traynor</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Nalls</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Arepalli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dillman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rafferty</surname>
<given-names>IP</given-names>
</name>
<name>
<surname>Troncoso</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain</article-title>
<source/>PLoS Genet
          <year>2010</year>
<volume>6</volume>
<fpage>e1000952</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1000952</pub-id>
<pub-id pub-id-type="pmid">20485568</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hannon</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Spiers</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Viana</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pidsley</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Burrage</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Troakes</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Turecki</surname>
<given-names>G</given-names>
</name>
<name>
<surname>O'Donovan</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Schalkwyk</surname>
<given-names>LC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Methylation QTLs in the developing brain and their enrichment in schizophrenia risk loci</article-title>
<source/>Nat Neurosci
          <year>2016</year>
<volume>19</volume>
<fpage>48</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="doi">10.1038/nn.4182</pub-id>
<pub-id pub-id-type="pmid">26619357</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Badner</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Craig</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Redman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gershon</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Genetic control of individual differences in gene-specific methylation in human brain</article-title>
<source/>Am J Hum Genet
          <year>2010</year>
<volume>86</volume>
<fpage>411</fpage>
<lpage>419</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2010.02.005</pub-id>
<pub-id pub-id-type="pmid">20215007</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edghill</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Bingham</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ellard</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hattersley</surname>
<given-names>AT</given-names>
</name>
</person-group>
<article-title>Mutations in hepatocyte nuclear factor-1beta and their related phenotypes</article-title>
<source/>J Med Genet
          <year>2006</year>
<volume>43</volume>
<fpage>84</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2005.032854</pub-id>
<pub-id pub-id-type="pmid">15930087</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shepherd</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shields</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hammersley</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hudson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Colclough</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Oram</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hyde</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes</article-title>
<source/>Diabetes Care
          <year>2016</year>
<volume>39</volume>
<fpage>1879</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="doi">10.2337/dc16-0645</pub-id>
<pub-id pub-id-type="pmid">27271189</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>R Core Team</collab>
</person-group>
<source/>R: a language and environment for statistical computing
          <year>2015</year>
<publisher-loc>Vienna</publisher-loc>
<publisher-name>R Foundation for Statistical Computing</publisher-name>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aryee</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Jaffe</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Corrada-Bravo</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ladd-Acosta</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Feinberg</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Irizarry</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Minfi: a flexible and comprehensive bioconductor package for the analysis of Infinium DNA methylation microarrays</article-title>
<source/>Bioinformatics
          <year>2014</year>
<volume>30</volume>
<fpage>1363</fpage>
<lpage>1369</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btu049</pub-id>
<pub-id pub-id-type="pmid">24478339</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Davis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bilke</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Triche</surname>
<given-names>T</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Bootwalla</surname>
<given-names>M</given-names>
</name>
</person-group>
<source/>methylumi: Handle Illumina methylation data. R package version 2.17.0
          <year>2015</year>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>YA</given-names>
</name>
<name>
<surname>Lemire</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Choufani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Butcher</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Grafodatskaya</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zanke</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Gallinger</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hudson</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Weksberg</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray</article-title>
<source/>Epigenetics
          <year>2013</year>
<volume>8</volume>
<fpage>203</fpage>
<lpage>209</lpage>
<pub-id pub-id-type="doi">10.4161/epi.23470</pub-id>
<pub-id pub-id-type="pmid">23314698</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Price</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Cotton</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Farre</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Emberly</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>WP</given-names>
</name>
<name>
<surname>Kobor</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array</article-title>
<source/>Epigenetics Chromatin
          <year>2013</year>
<volume>6</volume>
<fpage>4</fpage>
<pub-id pub-id-type="doi">10.1186/1756-8935-6-4</pub-id>
<pub-id pub-id-type="pmid">23452981</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pidsley</surname>
<given-names>R</given-names>
</name>
<name>
<surname>CC</surname>
<given-names>YW</given-names>
</name>
<name>
<surname>Volta</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lunnon</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mill</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schalkwyk</surname>
<given-names>LC</given-names>
</name>
</person-group>
<article-title>A data-driven approach to preprocessing Illumina 450K methylation array data</article-title>
<source/>BMC Genomics
          <year>2013</year>
<volume>14</volume>
<fpage>293</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2164-14-293</pub-id>
<pub-id pub-id-type="pmid">23631413</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delaney</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Yung</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Analysis of DNA methylation by pyrosequencing</article-title>
<source/>Methods Mol Biol
          <year>2015</year>
<volume>1343</volume>
<fpage>249</fpage>
<lpage>264</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-4939-2963-4_19</pub-id>
<pub-id pub-id-type="pmid">26420722</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horvath</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>DNA methylation age of human tissues and cell types</article-title>
<source/>Genome Biol
          <year>2013</year>
<volume>14</volume>
<fpage>R115</fpage>
<pub-id pub-id-type="doi">10.1186/gb-2013-14-10-r115</pub-id>
<pub-id pub-id-type="pmid">24138928</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Houseman</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Accomando</surname>
<given-names>WP</given-names>
</name>
<name>
<surname>Koestler</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Christensen</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Marsit</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Wiencke</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Kelsey</surname>
<given-names>KT</given-names>
</name>
</person-group>
<article-title>DNA methylation arrays as surrogate measures of cell mixture distribution</article-title>
<source/>BMC Bioinformatics
          <year>2012</year>
<volume>13</volume>
<fpage>86</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2105-13-86</pub-id>
<pub-id pub-id-type="pmid">22568884</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koestler</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Christensen</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Karagas</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Marsit</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Langevin</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Kelsey</surname>
<given-names>KT</given-names>
</name>
<name>
<surname>Wiencke</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Houseman</surname>
<given-names>EA</given-names>
</name>
</person-group>
<article-title>Blood-based profiles of DNA methylation predict the underlying distribution of cell types: a validation analysis</article-title>
<source/>Epigenetics
          <year>2013</year>
<volume>8</volume>
<fpage>816</fpage>
<lpage>826</lpage>
<pub-id pub-id-type="doi">10.4161/epi.25430</pub-id>
<pub-id pub-id-type="pmid">23903776</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feber</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Guilhamon</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lechner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fenton</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Thirlwell</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Flanagan</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Teschendorff</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Beck</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Using high-density DNA methylation arrays to profile copy number alterations</article-title>
<source/>Genome Biol
          <year>2014</year>
<volume>15</volume>
<fpage>R30</fpage>
<pub-id pub-id-type="doi">10.1186/gb-2014-15-2-r30</pub-id>
<pub-id pub-id-type="pmid">24490765</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pedersen</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>IV</given-names>
</name>
<name>
<surname>Kechris</surname>
<given-names>KJ</given-names>
</name>
</person-group>
<article-title>Comb-p: software for combining, analyzing, grouping and correcting spatially correlated P-values</article-title>
<source/>Bioinformatics
          <year>2012</year>
<volume>28</volume>
<fpage>2986</fpage>
<lpage>2988</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/bts545</pub-id>
<pub-id pub-id-type="pmid">22954632</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hannon</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dempster</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Viana</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Burrage</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Macdonald</surname>
<given-names>R</given-names>
</name>
<name>
<surname>St Clair</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mustard</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Breen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Therman</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation</article-title>
<source/>Genome Biol
          <year>2016</year>
<volume>17</volume>
<fpage>176</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-016-1041-x</pub-id>
<pub-id pub-id-type="pmid">27572077</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Amen-Hellebrekers</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pfundt</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schuurs-Hoeijmakers</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Koolen</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Marcelis</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>de Leeuw</surname>
<given-names>N</given-names>
</name>
<name>
<surname>de Vries</surname>
<given-names>BB</given-names>
</name>
</person-group>
<article-title>Duplications of SLC1A3: associated with ADHD and autism</article-title>
<source/>Eur J Med Genet
          <year>2016</year>
<volume>59</volume>
<fpage>373</fpage>
<lpage>376</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejmg.2016.06.003</pub-id>
<pub-id pub-id-type="pmid">27296938</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bedont</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>LeGates</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Slat</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Byerly</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rupp</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Herzog</surname>
<given-names>ED</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lhx1 controls terminal differentiation and circadian function of the suprachiasmatic nucleus</article-title>
<source/>Cell Rep
          <year>2014</year>
<volume>7</volume>
<fpage>609</fpage>
<lpage>622</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2014.03.060</pub-id>
<pub-id pub-id-type="pmid">24767996</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kwan</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Mailloux</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>WK</given-names>
</name>
<name>
<surname>Grinberg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wurst</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Behringer</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Westphal</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>LIM-homeodomain proteins Lhx1 and Lhx5, and their cofactor Ldb1, control Purkinje cell differentiation in the developing cerebellum</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2007</year>
<volume>104</volume>
<fpage>13182</fpage>
<lpage>13186</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0705464104</pub-id>
<pub-id pub-id-type="pmid">17664423</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drews</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Senkel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ryffel</surname>
<given-names>GU</given-names>
</name>
</person-group>
<article-title>The nephrogenic potential of the transcription factors osr1, osr2, hnf1b, lhx1 and pax8 assessed in Xenopus animal caps</article-title>
<source/>BMC Dev Biol
          <year>2011</year>
<volume>11</volume>
<fpage>5</fpage>
<pub-id pub-id-type="doi">10.1186/1471-213X-11-5</pub-id>
<pub-id pub-id-type="pmid">21281489</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lokmane</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Heliot</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Garcia-Villalba</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fabre</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cereghini</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>vHNF1 functions in distinct regulatory circuits to control ureteric bud branching and early nephrogenesis</article-title>
<source/>Development
          <year>2010</year>
<volume>137</volume>
<fpage>347</fpage>
<lpage>357</lpage>
<pub-id pub-id-type="doi">10.1242/dev.042226</pub-id>
<pub-id pub-id-type="pmid">20040500</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohanty</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Akmamedova</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Komurov</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Selective DNA methylation in cancers controls collateral damage induced by large structural variations</article-title>
<source/>Oncotarget.
          <year>2017</year>
<volume>8</volume>
<fpage>71385</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="pmid">29069713</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O'Donovan</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Hasselfeld</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Simmons</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Roussos</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Haroutunian</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Meador-Woodruff</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>McCullumsmith</surname>
<given-names>RE</given-names>
</name>
</person-group>
<article-title>Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia</article-title>
<source/>Transl Psychiatry
          <year>2015</year>
<volume>5</volume>
<fpage>e579</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2015.74</pub-id>
<pub-id pub-id-type="pmid">26057049</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Shield</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Leclerc</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Knauf</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Burcelin</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Rutter</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Kelsey</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Impaired glucose homeostasis in transgenic mice expressing the human transient neonatal diabetes mellitus locus, TNDM</article-title>
<source/>J Clin Invest
          <year>2004</year>
<volume>114</volume>
<fpage>339</fpage>
<lpage>348</lpage>
<pub-id pub-id-type="doi">10.1172/JCI200419876</pub-id>
<pub-id pub-id-type="pmid">15286800</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Rousseau</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ounissi-Benkalha</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Marchand</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jetha</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Paraskevas</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Goodyer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Polychronakos</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Differential expression pattern of ZAC in developing mouse and human pancreas</article-title>
<source/>J Mol Histol
          <year>2011</year>
<volume>42</volume>
<fpage>129</fpage>
<lpage>136</lpage>
<pub-id pub-id-type="doi">10.1007/s10735-011-9315-9</pub-id>
<pub-id pub-id-type="pmid">21305342</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>